Huaheng Biological: Hong Kong Stock Exchange reviews company's application to issue H-shares and list on the Main Board

robot
Abstract generation in progress
On June 7th, Huaheng Biological announced that the company is in the process of applying for an overseas listing of shares (H-shares) and listing on the Main Board of The Stock Exchange of Hong Kong Limited.
The Listing Committee of the Hong Kong Stock Exchange held a hearing on June 4, 2026, to review the company's application for the proposed listing.
The company's sponsor for this issuance and listing received a letter from the Hong Kong Stock Exchange on June 5, 2026, which stated that the Listing Committee of the Hong Kong Stock Exchange had reviewed the company's listing application, but this letter does not constitute formal approval for the listing, and the Hong Kong Stock Exchange still reserves the right to provide further comments on the company's listing application.
(Interface)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned